Sara Hall, MD; Annika Öhrfelt, PhD; Radu Constantinescu, MD; et al.
free access
Arch Neurol. 2012;69(11):1445-1452. doi:10.1001/archneurol.2012.1654
Hall et al assess the ability of 5 biomarkers in 453 cerebrospinal fluid samples in the ability to differentiate between common dementia and parkinsonian disorders. In a related editorial, Perrin discusses why markers for differential diagnosis are important.
Qiaoshu Wang, MD; Christopher Chen, FRCP; Xiang Yan Chen, MD; et al.
free access
Arch Neurol. 2012;69(11):1454-1460. doi:10.1001/archneurol.2012.1633
Wang and colleagues reported a post-hoc analysis of a randomized aspirincontrolled trial exploring the efficacy and safety of low-molecular-weight heparin (LMWH) for early neurologic deterioration (END) in patients with acute ischemic stroke and large artery occlusive disease.
Stephane Olindo, MD; Nicolas Chausson, MD; Julien Joux, MD; et al.
free access
Arch Neurol. 2012;69(11):1462-1468. doi:10.1001/archneurol.2012.1310
Olindo et al assess a fluid-attenuated inversion recovery (FLAIR) vascular hyperintensities score and explore its relationship with recanalization status and clinical outcomes after intravenous thrombolysis.
Jeong-Min Kim, MD; Keun-Hwa Jung, MD, PhD; Chul-Ho Sohn, MD, PhD; et al.
free access
Arch Neurol. 2012;69(11):1470-1475. doi:10.1001/archneurol.2012.1018
Kim and colleagues studied patients with middle cerebral artery (MCA) territory infarction or transient ischemic attack to evaluate atherosclerosis activity of the MCA by high-resolution magnetic resonance imaging and determine its relationship with infarction patterns.
Jamie J. Van Gompel, MD; Ruth Ottman, PhD; Gregory A. Worrell, MD, PhD; et al.
free access
Arch Neurol. 2012;69(11):1476-1481. doi:10.1001/archneurol.2012.1200
In a population-based cohort study, Van Gompel et al assess the hypothesis that use of anterior temporal lobectomy for temporal epilepsy has diminished over time.
Peiqing Qian, MD; Samantha Lancia, MS; Enrique Alvarez, MD, PhD; et al.
free access
Arch Neurol. 2012;69(11):1482-1487. doi:10.1001/archneurol.2012.768
In a retrospective, cross-sectional cohort study, Qian et al contrast differences in pain and treatment outcomes between neuromyelitis optica and multiple sclerosis.
Timo Siepmann, MD; Christopher H. Gibbons, MD, MMSc; Ben M. Illigens, MD; et al.
free access
Arch Neurol. 2012;69(11):1488-1492. doi:10.1001/archneurol.2012.1092
Siepmann and colleagues conducted a hospital-based study involving 22 healthy volunteers aged 24 to 48 years to quantify piloerection using phenylephrine in humans.
Ricarda A. L. Menke, PhD; Ivy Abraham, BSc; Catherine S. Thiel; et al.
free access
Arch Neurol. 2012;69(11):1493-1498. doi:10.1001/archneurol.2012.1122
Menke and colleagues studied 21 patients with amyotrophic lateral sclerosis (ALS) and 3 patients with primary lateral sclerosis to explore the value of diffusion tensor imaging applied to those specific cerebral white matter tracts consistently involved pathologically in amyotrophic lateral sclerosis as a source of prognostic biomarkers.